BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiu MH, Wang DM, Du XD, Chen N, Tan SP, Tan YL, Yang FD, Cho RY, Zhang XY. Interaction of BDNF and cytokines in executive dysfunction in patients with chronic schizophrenia. Psychoneuroendocrinology 2019;108:110-7. [DOI: 10.1016/j.psyneuen.2019.06.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Ye Q, Zhang Y, Zhang Y, Chen Z, Yu C, Zheng C, Yu H, Zhou D, Li X. Low VGF is associated with executive dysfunction in patients with major depressive disorder. J Psychiatr Res 2022;152:182-6. [PMID: 35738161 DOI: 10.1016/j.jpsychires.2022.06.030] [Reference Citation Analysis]
2 Zhu S, Zhao L, Fan Y, Lv Q, Wu K, Lang X, Li Z, Yi Z, Geng D. Interaction between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia. Psychoneuroendocrinology 2020;114:104595. [DOI: 10.1016/j.psyneuen.2020.104595] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
3 Zhou X, Tian B, Han HB. Serum interleukin-6 in schizophrenia: A system review and meta-analysis. Cytokine 2021;141:155441. [PMID: 33529887 DOI: 10.1016/j.cyto.2021.155441] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Tsai S. Role of interleukin 8 in depression and other psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2021;106:110173. [DOI: 10.1016/j.pnpbp.2020.110173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Guan X, Xu J, Xiu M, Li X, Liu H, Wu F. Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal study. CNS Neurosci Ther 2022. [PMID: 35769008 DOI: 10.1111/cns.13895] [Reference Citation Analysis]
6 Wu ZW, Yu HH, Wang X, Guan HY, Xiu MH, Zhang XY. Interrelationships Between Oxidative Stress, Cytokines, and Psychotic Symptoms and Executive Functions in Patients With Chronic Schizophrenia. Psychosom Med 2021;83:485-91. [PMID: 34080586 DOI: 10.1097/PSY.0000000000000931] [Reference Citation Analysis]
7 Wu Y, Du X, Yang R, Yue Y, Peng R, Wu S, Wang H, Zhou Y, Fang X, Yuan N, Li R, Zhang J, Zou S, Zhao X, Lyu X, Li Z, Zhang X, Zhang X. Association Between Depressive Symptoms and Serum Brain-Derived Neurotrophic Factor Levels in Patients With First-Episode and Drug-Naïve Schizophrenia. Front Psychiatry 2022;13:911384. [PMID: 35757201 DOI: 10.3389/fpsyt.2022.911384] [Reference Citation Analysis]
8 Qu M, Wang J, Chen DC, Chen S, Xiu MH, Zhang XY. Sex-specific association between peripheral superoxide dismutase, BDNF and cognitive impairment in drug-naive first episode patients with schizophrenia. Free Radic Biol Med 2020;160:887-93. [PMID: 32949664 DOI: 10.1016/j.freeradbiomed.2020.09.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Liu J, Xiu M, Liu H, Wang J, Li X. Plasma Lysophosphatidylcholine and Lysophosphatidylethanolamine Levels Were Associated With the Therapeutic Response to Olanzapine in Female Antipsychotics-naïve First-episode Patients With Schizophrenia. Front Pharmacol 2021;12:735196. [PMID: 34603051 DOI: 10.3389/fphar.2021.735196] [Reference Citation Analysis]
10 Wei C, Sun Y, Chen N, Chen S, Xiu M, Zhang X. Interaction of oxidative stress and BDNF on executive dysfunction in patients with chronic schizophrenia. Psychoneuroendocrinology 2020;111:104473. [DOI: 10.1016/j.psyneuen.2019.104473] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
11 Huang Z, Kang M, Li G, Xiong P, Chen H, Kang L, Li S, Lu C, Li Q, Bai M. Predictive effect of Bayes discrimination in the level of serum protein factors and cognitive dysfunction in schizophrenia. Journal of Psychiatric Research 2022;151:539-45. [DOI: 10.1016/j.jpsychires.2022.05.004] [Reference Citation Analysis]
12 Wu Z, Liu Q, Zhang Y, Guan X, Xiu M, Zhang X. Superoxide dismutase, BDNF and cognitive improvement in drug-naive first episode patients with schizophrenia: a 12-week longitudinal study. Int J Neuropsychopharmacol 2021:pyab065. [PMID: 34622272 DOI: 10.1093/ijnp/pyab065] [Reference Citation Analysis]
13 Chumakov E, Dorofeikova M, Tsyrenova K, Petrova N. A Cross-Sectional Study on Associations Between BDNF, CRP, IL-6 and Clinical Symptoms, Cognitive and Personal Performance in Patients With Paranoid Schizophrenia. Front Psychiatry 2022;13:943869. [PMID: 35873262 DOI: 10.3389/fpsyt.2022.943869] [Reference Citation Analysis]
14 Noto MN, Maes M, Vargas Nunes SO, Ota VK, Cavalcante D, Oliveira G, Rossaneis AC, Verri WA Jr, Cordeiro Q, Belangero SI, Gadelha A, Noto C, Bressan RA. BDNF in antipsychotic naive first episode psychosis: Effects of risperidone and the immune-inflammatory response system. J Psychiatr Res 2021;141:206-13. [PMID: 34246975 DOI: 10.1016/j.jpsychires.2021.07.011] [Reference Citation Analysis]
15 Dombi ZB, Szendi I, Burnet PWJ. Brain Derived Neurotrophic Factor and Cognitive Dysfunction in the Schizophrenia-Bipolar Spectrum: A Systematic Review and Meta-Analysis. Front Psychiatry 2022;13:827322. [PMID: 35686181 DOI: 10.3389/fpsyt.2022.827322] [Reference Citation Analysis]
16 Wu ZW, Shi H, Chen DC, Chen S, Xiu MH, Zhang XY. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study. Psychoneuroendocrinology 2020;122:104879. [PMID: 33049658 DOI: 10.1016/j.psyneuen.2020.104879] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
17 Tong J, Zhang J, Jin Y, Liu W, Wang H, Huang Y, Shi D, Zhu M, Zhu N, Zhang T, Sun X. Impact of Repetitive Transcranial Magnetic Stimulation (rTMS) on Theory of Mind and Executive Function in Major Depressive Disorder and Its Correlation with Brain-Derived Neurotrophic Factor (BDNF): A Randomized, Double-Blind, Sham-Controlled Trial. Brain Sci 2021;11:765. [PMID: 34207545 DOI: 10.3390/brainsci11060765] [Reference Citation Analysis]
18 Xiao L, Tang X, Hu X, Feng X, Gong R, Wang F, Zhang X. Serum Level of Growth-Associated Protein 43 Is Associated with First-Episode Schizophrenia Patients without Antipsychotic Drugs Treatment. Comput Intell Neurosci 2022;2022:4719271. [PMID: 35615548 DOI: 10.1155/2022/4719271] [Reference Citation Analysis]
19 Valiuliene G, Valiulis V, Dapsys K, Vitkeviciene A, Gerulskis G, Navakauskiene R, Germanavicius A. Brain stimulation effects on serum BDNF, VEGF, and TNFα in treatment-resistant psychiatric disorders. Eur J Neurosci 2021;53:3791-802. [PMID: 33861484 DOI: 10.1111/ejn.15232] [Reference Citation Analysis]